Company intelligence
eXoZymes (Nasdaq: EXOZ)
Pioneering AI-enhanced enzymes that can transform sustainable feedstock into nutraceuticals and new medicines.
Biotechnology
Monrovia, US
11–50 employees
Founded 2019
1 public signals
About eXoZymes (Nasdaq: EXOZ)
eXoZymes has developed a next gen biomanufacturing platform capable of producing highly valuable natural products. As a historic first, this cell-free platform offers the bioengineering tools and design-control to run nature’s own natural enzyme pathways without living cells. AI is used to genetically optimize the cell-free enzymes - called exozymes - to thrive in a bioreactor outside the cell.
Verified activity
Signals from eXoZymes (Nasdaq: EXOZ)
1 published signal